Author + information
- Kristin J. Lyonsa,b,
- Justin Ezekowitza,b,
- Li Lianga,b,
- Paul Heidenreicha,b,
- Clyde Yancya,b,
- Adam DeVorea,b,
- Adrian F. Hernandeza,b and
- Gregg Fonarowa,b
Background: The 2013 heart failure (HF) guidelines of the American College of Cardiology Foundation and American Heart Association (ACCF-AHA) restricted the indications for chronic resynchronization therapy (CRT). The impact of this guideline change has not been described.
Methods: Using data from the Get With The Guidelines-HF registry between 2012 and 2015, we evaluated the proportion of hospitalized HF patients eligible for CRT based on historic and current guideline recommendations. We identified 25, 102 hospitalizations for HF that included patients with a left ventricular ejection fraction (LVEF) ≤ 35% from 283 hospitals. Patients with a documented medical or patient reason for not prescribing CRT were excluded.
Results: Overall, 49% (n=12336) of patients were eligible for CRT based on historic guidelines and 34% (n=8,414) of patients were eligible for CRT based on current guidelines. There were no significant differences in patient sex, LVEF, HF etiology or other baseline characteristics between the two groups. Amongst patients eligible for CRT based on historic and current guidelines, there were no significant differences in baseline characteristics or in the proportion of patients who had CRT placed or prescribed at discharge (Table).
Conclusions: In a hospitalized HF population with an LVEF ≤ 35% and without a documented reason for not prescribing device therapy, the current ACCF-AHA HF guidelines reduce the proportion of patients eligible for CRT by 15%.
Poster Hall, Hall C
Friday, March 17, 2017, 3:45 p.m.-4:30 p.m.
Session Title: Acute Heart Failure: Evaluating Strategies to Prevent Readmissions
Abstract Category: 13. Heart Failure and Cardiomyopathies: Clinical
Presentation Number: 1163-276
- 2017 American College of Cardiology Foundation